Pfizer suffers heavy setback, net dips by 77% in Q3
Thursday, October 18, 2007 17:45 IST Our Buraeu, Mumbai
Pfizer Ltd, a world leader in the pharmaceutical segment, suffered heavy setback during the third quarter of 2007 mainly due to the loss of US exclusivity of Zoloft in June 2006 and for Norvasc in March 2007.
